Tenet Healthcare (THC) Cash & Equivalents (2009 - 2026)

Tenet Healthcare has disclosed Cash & Equivalents across 18 years of filings, most recently posting $3.0 billion for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $3.0 billion, down 1.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.0 billion (down 1.07% YoY), and the FY2025 annual result was $2.9 billion, down 4.5% from the prior year.
• Cash & Equivalents came in at $3.0 billion for Q1 2026 at Tenet Healthcare, up from $2.9 billion in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $4.1 billion in Q3 2024 to a low of $766.0 million in Q1 2023.
• The 5-year median for Cash & Equivalents is $2.5 billion (2024), against an average of $2.1 billion.
• Across the five-year window, Cash & Equivalents plunged 63.71% in 2022 and surged 288.43% in 2024, its largest moves.
• Tenet Healthcare's Cash & Equivalents stood at $858.0 million in 2022, then jumped by 43.12% to $1.2 billion in 2023, then surged by 145.85% to $3.0 billion in 2024, then decreased by 4.5% to $2.9 billion in 2025, then climbed by 2.91% to $3.0 billion in 2026.
• The last three Cash & Equivalents figures came in at $3.0 billion (Q1 2026), $2.9 billion (Q4 2025), and $3.0 billion (Q3 2025), per Business Quant data.